An Innovative Control Strategy to Improve the Fault Ride-Through Capability of DFIGs Based on Wind Energy Conversion Systems

An innovative control strategy is proposed for enhancing the low voltage ride-through (LVRT) capability of a doubly fed induction generator based on wind energy conversion systems (DFIG-WECS). Within the proposed control method, the current control loops of the rotor side converter (RSC) are developed based on passivity theory. The control scheme for the grid side converter (GSC) is designed based on a two-term approach to keep the DC-link voltage close to a given value. The first term based on the maximal voltage of GSC is introduced in the GSC control loops as a reference reactive current. The second one reflecting the instantaneous unbalanced power flow between the RSC and GSC is also introduced in the GSC control loops as a disturbance considering the instantaneous power of the grid filter to compensate the instantaneous rotor power. The effectiveness of the proposed control strategy is verified via time domain simulation of a 2.0 MW-575 V DFIG-WECS using PSCAD/EMTP. Simulation results show that the control of the DFIG with the proposed approach can improve the LVRT capability better than with the conventional one

Anti-hypertensive effects of Callisia fragrans extract on Reno-vascular hypertensive rats

Objectives This study aims to investigate the anti-hypertensive effects of aqueous extract of Callisia fragrans and their underlying mechanism using a two-kidney one-clip (2K1C) model of reno-vascular hypertension in rats. Methods The reno-vascular hypertensive rats were treated with C. fragrans leaf extract (100 and 500 mg/kg; p.o.) and a reference drug, captopril (20 mg/kg; p.o.), for 4 weeks. The blood pressure and heart rate were recorded using a tail-cuff. The heart weight, left ventricular wall thickness, and serum creatinine and urea levels were measured. A spectrophotometric assay was used to analyze the angiotensin-converting enzyme (ACE) inhibition activity of the extract and the reference drug. The total volume and the concentration of sodium, potassium, and chloride in urine samples were evaluated. Results C. fragrans extract significantly reduced both systolic and diastolic blood pressures in the reno-vascular hypertensive rats. No significant difference in the heart rate was observed between each animal group. C. fragrans extract reduced the 2K1C-induced increase in the heart and body weight ratio and the left ventricular wall thickness. Moreover, the extract also attenuated the increase in serum urea induced by the 2K1C treatment. C. fragrans extract inhibited ACE activity in vitro with an IC50 of 20.97 ± 3.94 µg/ml. The urine output and urinary electrolyte excretion significantly increased in C. fragrans extract-treated rats. Conclusions These findings demonstrated that C. fragrans extract can mitigate hypertension and alleviate ventricular hypertrophy and renal dysfunction in reno-vascular hypertensive rats, at least in part via ACE activity inhibition and diuretic property

Eggshell powder as calcium source on growth and yield of groundnut (Arachis hypogaea L.)

ABSTRACTThe use of eggshells as an alternative source of calcium carbonate for groundnut can reduce the impact on the natural reserves of limestone, a non-renewable natural source. This study aimed to investigate the effects of eggshell powder application on the growth and yield of groundnut. The calcium treatments were lime application (A0) at 500 kg ha−1 and four rates of eggshell powder application including A1 (200 kg ha−1), A2 (300 kg ha−1), A3 (400 kg ha−1), and A4 (500 kg ha−1). Two application times, T1 (applying 5-days before sowing) and T2 (applying 5-days after flowering) were employed. The result showed that eggshell powder could be a useful alternative source to supply Ca for groundnut. Application of eggshell powder before sowing resulted in significantly higher pod yield and total calcium uptake with better growth parameters than after flowering. Increasing eggshell powder application rates also increased soil pH and calcium contents, and plant calcium uptake. The application rate of eggshell powder before sowing at the rate of 300 kg ha−1 produced the highest pod yield and was suggested to be optimum

Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination

Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community. Funding: The GenRe-Mekong project is funded by the Bill and Melinda Gates Foundation (OPP11188166, OPP1204268). Genotyping and sequencing were funded by the Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z) and Medical Research Council (G0600718). A proportion of samples were collected with the support of the UK Department for International Development (201900, M006212), and Intramural Research Program of the National Institute of Allergy and Infectious Diseases